On August 11, Rocket Lab USA, Inc. declined 6.73% overnight, trading at $74.22/share, with turnover of $573,900. The sell-off followed the company's mixed Q2 earnings release and weak Q3 profitability guidance.

Rocket Lab reported Q2 revenue of $234.1 million, up 62% year-over-year and slightly beating the $231.6 million consensus estimate. However, EPS came in at a loss of $0.08, missing analyst expectations of a $0.06-$0.07 loss. More critically, the company guided Q3 GAAP gross margin at 29%-31%, significantly below the Street's 37.6% estimate, citing shifts in product sales mix. Management also signaled potential new delays for the Neutron rocket program, a key long-term growth driver.

On the positive side, backlog reached a record $2.36 billion with over 90 launch missions pending, and Q3 revenue guidance of $250-$265 million exceeded the $238.5 million consensus. The company recently secured over $660 million in defense contracts, including a $397 million US Space Force Flatellites deal and a $266 million missile defense launch contract.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)